Stocks and Investing Stocks and Investing
Fri, August 2, 2024

Joseph Stringer Maintained (ALNY) at Strong Buy with Increased Target to $320 on, Aug 2nd, 2024


Published on 2024-10-28 13:05:20 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $275 to $320 on, Aug 2nd, 2024.

Joseph has made no other calls on ALNY in the last 4 months.



There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 3 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Olivia Brayer of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $220 on, Monday, July 22nd, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $255 on, Friday, July 12th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Hold with Increased Target to $248 on, Wednesday, July 3rd, 2024


These are the ratings of the 7 analyists that currently disagree with Joseph


  • Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $288 on, Friday, June 28th, 2024
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $295 on, Thursday, June 27th, 2024
  • Ritu Baral of "TD Cowen" Maintained at Strong Buy with Increased Target to $282 on, Tuesday, June 25th, 2024
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $260 on, Tuesday, June 25th, 2024
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $400 on, Monday, June 24th, 2024
  • Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $234 on, Monday, June 24th, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $225 on, Friday, May 3rd, 2024
Contributing Sources